* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Document 8925442
Vectors in gene therapy wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
DNA sequencing wikipedia , lookup
DNA vaccination wikipedia , lookup
DNA polymerase wikipedia , lookup
Transposable element wikipedia , lookup
DNA profiling wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
Human genome wikipedia , lookup
Molecular cloning wikipedia , lookup
Zinc finger nuclease wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenomics wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Neocentromere wikipedia , lookup
Nucleic acid double helix wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Genealogical DNA test wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Non-coding DNA wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Genomic library wikipedia , lookup
Microevolution wikipedia , lookup
DNA supercoil wikipedia , lookup
Frameshift mutation wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Genome editing wikipedia , lookup
Metagenomics wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
SNP genotyping wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Helitron (biology) wikipedia , lookup
Point mutation wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
03-131 Genes, Drugs, and Disease Problem Set 5 Due October 14, 2015 What you should have learned from this problem set: Only triphosphates can be added by polymerases Antiviral drugs that are competitive inhibitors of polymerases can become terminators after the addition of three phosphates. How to determine the effect of DNA mutations on HIV protease – reading a sequencing gel, determining the reading frame, using the codon table. How to counteract changes at Val82 in the protease by introducing complementary interactions in a new drug. PCR can be used to amplify tandem repeats, provided the primers are outside the repeated region. If the tandem repeats differ between two samples, the samples must have come from different individuals. If the tandem repeats are the same in two samples (e.g. blood from a crime scene and blood taken from a possible suspect) they do not necessarily have to come from the same person, many individuals will have the same tandem repeats. Thus, this technique can only be used to exclude identity matches, not prove them. 1. (10 pts, 10 min) AZT is a competitive inhibitor of HIV reverse transcriptase. Its structure is shown on the right, along with one of the normal substrates for the enzyme, dTTP. i) Why is it not possible for AZT to be incorporated into the growing polymer? It is missing three phosphate groups. Only Substrate triphosphates can be added to the 3’OH by (dTTP) polymerases. ii) What would have to be added to the AZT such that it could be added to the primer by a polymerase? (AZT) Three phosphates, to make it a triphosphate. iii) If AZT were used by a polymerase, would elongation (addition of the next base) be possible? Why or why not? No, it has no 3’ OH so it is a chain terminator, just like the dideoxy bases used in DNA sequencing. This would prevent the entire HIV vRNA to be converted to DNA. 2. (10 pts, 5 min) Acyclovir is an antiviral agent. The structure of acyclovir and guanosine (deoxy) are shown on the right. i) Use the web to find out what kind of viral infections are typically treated with acyclovir. Herpes simplex. ii) How do you think acyclovir works to inhibit replication of the virus? Same as AZT. The drug itself would be a competitive inhibitor of replication, when phosphorylated to the triphosphate, it would also terminate growing chains because it lacks a 3’OH. 3. (15 pts, 25 min) Two sequencing reactions are shown below. The top sequence is of a mutant HIV protease gene and the bottom is from a wild-type virus. Your ultimate goal is to determine how a mutation may have affected binding of the drug to the HIV protease. You will need to download the problem set to get the data in color. Sequence files are also downloadable, if you want to use bioinformatics tools (recommended). You can translate the DNA sequence at: http://web.expasy.org/translate/. (This will give the one letter code for the amino acids, a conversion chart is given on the last page of this problem set.) Alternatively you can use Blastn to align the mutant sequence data to the wildtype sequence. 1 03-131 Genes, Drugs, and Disease Problem Set 5 Due October 14, 2015 i) Determine the change in the DNA sequence and the resultant change in protein sequence. You will need to consult the known DNA/protein sequence of HIV protease (see lecture notes) to determine the correct reading frame. ii) Does this mutation affect the substrate specificity of HIV protease (the types of substrates it likes to act on), or the ability of the enzyme to cleave peptide bonds? Why? iii) The anti-viral drug that inhibits HIV protease is shown on the right. OH O H H + How might you modify the drug such that it would bind, and H3C N N NH3 N effectively inhibit, the activity of the virus containing the mutant H O O O protease? To aid in the visualization of the enzyme-inhibitor complex, you can utilize the HIV jmol page for this problem set. This O NH2 Jmol page will allow you to load the structure of HIV protease with a number of different mutations – you need to determine the correct mutation (part i) to select the correct structure to view. i) The mutation is an Asp at residue 82, There are three ways you could have done this: a) “Manually” find the sequence difference – it occurs at position 44 in the sequence data. Starting reading from 41: WT: CTGTCAACA Mut:CTGACAACA Now you have to find this in the HIV protease sequence: 238 GGACATAAAGCTATAGGTACAGTATTAGTAGGACCTACACCTGTCAACATAATTGGAAGA297 68GlyHisLysAlaIleGlyThrValLeuValGlyProThrProValAsnIleIleGlyArg87 We see that the third reading frame is correct for how I read the sequences: WT: CT GTC AAC A Mut:CT GAC AAC A So Valine82 (GTC) has been changed to Asp(GAC). b) you can translate the DNA sequence using Expasy and find the mutation that way. c) you can align the mutant sequence to the wild-type using Blastn Methods b and c were done in class, see lecture 16. The mutation (Val to Asp) would affects substrate specificity because it changes the specificity pocket. An effective drug would replace the cyclohexane ring with a + charged amino group (the identical change was on the last problem set, see Q8, problem set 4). 4. (10 pts, 15 min) Solve the following forensic case. Tandem repeats(3) DNA was isolated from the victim, collected from the crime scene, and from three suspects. The DNA Chromosome was subjected to PCR using primers that amplify a region of the chromosome that is known to contain tandem repeats, which are sequences that are PCR product repeated multiple times on the same chromosome. The number of tandem repeats differs from one individual to another, causing the length of the PCR product to differ. 2 03-131 Genes, Drugs, and Disease Problem Set 5 Due October 14, 2015 For example one chromosome could look like this, with three tandem repeat (see above), while a chromosome might have four, giving a larger PCR product. Note that since we have two copies of each chromosome there are two possible PCR products, one from each chromosome. It is possible to have the same number of tandem repeats on each chromosome. After PCR the DNA was separated by size and stained to visualize the DNA fragments. In the image on the right shows the sizes of DNA fragments for each of the following samples: Lane 1 – Victim’s blood Lane 2 – Blood at crime scene (victim+criminal) Lane 3 - Suspect #1 Lane 4 - Suspect #2 Lane 5 - Suspect #3 Bands towards the bottom of the diagram are smaller. Bands at the same position have the same size. The circled band will be used for problem 5. i) Who is no longer a suspect? Please justify your answer. ii) On the basis of the above data, who is still a suspect for the crime? Please justify your answer. iii) Is the individual identified in part ii) definitely guilty? Each person will give rise to two PCR products, one from the chromosome they inherited from their mother, and one they inherited from their father. The size of the PCR products will be different if there a different number of repeats. They will be the same if the number of repeats is the same. If the number of repeats is the same, only one band will be seen after electrophoresis. Lane #2: Contains PCR products from two people, the victim and the culprit. Only three bands are seen because both the victim and the culprit have the same number of repeats on one of their chromosomes. So it is not possible to determine unambiguously which of the lower bands come from the culprit. The top band must come from the culprit. i) Lane 4, or suspect 2, cannot be a suspect since the DNA from this person has different repeats that the culprit. ii) Lanes 3 and 5 remain as suspects since the number of repeats they have could be the same as the culprit. They both have the upper product, and their other band matches the other two bands in lane 2. iii) No, they are not necessarily guilty because many other people in the population will have the same repeats as lane 3 or lane 5. 5. (10 pts, 15 min) The smallest PCR product (circled in the above image) was sequenced and its sequence was: GCTGTAGCCATTGGGCCCTTTAAAGGGCCCTTTAAAGGGCCCTTTAAACCGCGTGAGTCA i) What is the sequence of the tandem repeat? ii) How many tandem repeats are present in this DNA? iii) Give the sequence of the left and right PCR primers that would have been used to produce this PCR product. Assume that the PCR primers are 8 bases long. i) GGGCCCTTTAAA ii ) three iii) The left primer is the underlined sequence on the left., the right primer is the complement of the underlined region on the right. The exact primer isn’t important as long as they flank the repeats. Left primer 5’ CTGTAGCCATT Right primer 5’ TGACTCACGC 3